24 March 2016
A study carried out by Maisonneuve-Rosemont Hospital in Montreal has determined a common genetic defect in beta cells that impacts both type 1 and type 2 diabetes sufferers.
Published in the journal Nature Genetics, the research showed that diabetes should no longer be referred to as a 'lifestyle disease', given the strong genetic factor that the study has identified.
Sylvie Lesage, a member of the Montreal Diabetes Research Center, stated: "Our research finds that genetics is critical for the survival of beta cells - the cells that make insulin.
"Thanks to our genetic make-up, some of us have beta cells that are tough and robust, while others have beta cells that are fragile and can't handle stress."
It is now hoped that these findings could act as a catalyst for an improved understanding of the development of diabetes in patients in the future, while also potentially leading to new avenues of treatment.
Posted by Edward Bartel
Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.